Brainstorm Cell Therapeutics Inc (BCLI) Live Share Price, Invest From India

Brainstorm Cell Therapeutics Inc Stock Performance

as on May 6, 2026 at 6:19 am IST

Day's Low
$0.62
Day's Price Range
$0.69
$0.69
10.14%
Downside
52 Week's Low
52 Week's High
$0.46
52-Week Price Range
$1.92
$0.69
33.49%
Downside
178.26%
Upside

Brainstorm Cell Therapeutics Inc share price movements today

Previous Close: $0.65
Open: $0.62
Volume: 55.5K
Day's Low - High: $0.62 - $0.69
52 Week Low - High: $0.46 - $1.92

Brainstorm Cell Therapeutics Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Brainstorm Cell Therapeutics Inc Stock Fundamentals & Key Indicators

Check Brainstorm Cell Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.2M

EPS (TTM)

-1.07

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-9.8M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-1121.90%

Brainstorm Cell Therapeutics Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Brainstorm Cell Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Brainstorm Cell Therapeutics Inc	SELL	$7.2M	NA	NA	0.00%

Analyst Recommendation on Brainstorm Cell Therapeutics Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Brainstorm Cell Therapeutics Inc. Average target price of $17

Brainstorm Cell Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Brainstorm Cell Therapeutics Inc.

What analysts predicted

95.94%UPSIDE

Target Price

$17

Current Price

$0.69

Analyzed by

6 Analysts

Target

$17.00

Brainstorm Cell Therapeutics Inc target price $17, a slight upside of 95.94% compared to current price of $0.69. According to 6 analysts rating.

Brainstorm Cell Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	0	-	0	0	-	0	-	-	-	0
Gross Profit	0	0	0	0	0	0	0	-	-	0
Operating Income	-5	-6	-2	-2	-3	-3	-3	-2	-2	-2
EBITDA	-5	-5	-2	-2	-2	-3	-3	-2	-1	-2
Interest Expense	0	0	0	-	0	0	-	0	-	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-1	-3	-2	-2	-2	-2	-2	-2	-2
Income Tax Expense	0	-4	0	-	-	-	-	-	-	-
Net Income	-5	-1	-3	-2	-2	-2	-2	-2	-2	-2
Net Profit Margin	-3460.39%	0.00%	-991.55%	-696.16%	0.00%	-350.18%	0.00%	0.00%	0.00%	-346.23%

Brainstorm Cell Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	0	-	-	-	-	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	-
Operating Income	-5	-4	-14	-23	-31	-24	-24	-21	-11	-9
EBITDA	-4	-4	-13	-23	-31	-24	-24	-16	-11	-9
Interest Expense	0	0	0	0	0	0	0	-	0	-
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-4	-13	-23	-31	-24	-24	-17	11	-10
Income Tax Expense	0	0	0	0	0	0	0	-	11	-
Net Income	-4	-4	-13	-23	-31	-24	-23	-17	11	-10
Net Profit Margin	0.00%	0.00%	0.00%	6353.28%	0.00%	0.00%	0.00%	0.00%	1369.02%	-1466.15%

Brainstorm Cell Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-5	-3	-2	-2	-2	-2	-2	-2	-2
Operating Cash Flow	-3	-3	-1	-3	-1	-1	-3	-1	0
Investing Cash Flow	-	0	-	-	0	-	-	-	-
Financing Cash Flow	3	2	4	-	1	3	2	0	0
Change in Cash	0	0	2	-3	0	1	0	0	0

Brainstorm Cell Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-4	-13	-23	-31	-24	-24	-17	-11	-10
Operating Cash Flow	-2	-12	-11	-35	-26	-19	-20	-9	-6
Investing Cash Flow	3	-1	5	-4	0	0	2	0	-
Financing Cash Flow	0	12	5	76	6	0	18	7	6
Change in Cash	1	-1	0	37	-18	-18	0	-1	0

Global Institutional Holdings in Brainstorm Cell Therapeutics Inc

Funds	Holdings
BNP Paribas Arbitrage, SA	0%
Armistice Capital, LLC	7.02%
VSM Wealth Advisory, LLC	0%
CALDWELL SUTTER CAPITAL INC	1.6%
Northwestern Mutual Wealth Management Co	0%

See all

About Brainstorm Cell Therapeutics Inc

Brainstorm Cell Therapeutics Inc. a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company's NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is involved in the development of NurOwn, which has completed Phase IIIb clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for treatment of other neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Organisation	Brainstorm Cell Therapeutics Inc
Headquarters	1325 Avenue of Americas, New York, NY, United States, 10019
Industry	Biotechnology
CEO	Mr. Chaim Lebovits
E-voting on shares	Click here to vote

Key Management of Brainstorm Cell Therapeutics Inc

Name	Title
Dr. Daniel Offen Ph.D.	Chief Scientific Advisor
Ms. Mary Kay Turner	Senior Vice President of Patient Advocacy & Government Affairs
Dr. Netta Blondheim-Shraga Ph.D.	Senior Vice President of Research and Development
Mr. Chaim Lebovits	President & CEO
Dr. Ibrahim Dagher M.D.	Executive VP & Chief Medical Officer
Mr. Uri Yablonka	Executive VP, Chief Business Officer, Secretary & Director
Ms. Alla Patlis CPA, M.B.A.	Interim CFO & Controller
Dr. Hartoun Hartounian Ph.D.	Executive VP & COO

FAQs

What is Brainstorm Cell Therapeutics Inc share price today?

Brainstorm Cell Therapeutics Inc share price today is $0.69 as on May 6, 2026 at 12:49 am IST at the close of the market. Brainstorm Cell Therapeutics Inc share today touched a day high of $0.69 and a low of $0.62.

What is the 52 week high and 52 week low for Brainstorm Cell Therapeutics Inc share?

Brainstorm Cell Therapeutics Inc share touched a 52 week high of $1.92 on May 19, 2025 and a 52 week low of $0.46 on February 13, 2026. Brainstorm Cell Therapeutics Inc stock price today i.e. May 6, 2026 at 12:49 am IST is closed at $0.69,which is 64.06% down from its 52 week high and 50.36% up from its 52 week low.

What is Brainstorm Cell Therapeutics Inc's market capitalisation today?

Brainstorm Cell Therapeutics Inc market capitalisation is $0.00T as on May 6, 2026 at 12:49 am IST.

How to invest in Brainstorm Cell Therapeutics Inc Stock (BCLI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Brainstorm Cell Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Brainstorm Cell Therapeutics Inc Shares that will get you 2.1739 shares as per Brainstorm Cell Therapeutics Inc share price of $0.69 per share as on May 6, 2026 at 12:49 am IST.

What is the minimum amount required to buy Brainstorm Cell Therapeutics Inc Stock (BCLI) from India?

Indian investors can start investing in Brainstorm Cell Therapeutics Inc (BCLI) shares with as little as ₹95.28 or $1 (as of May 6, 2026 at 5:55 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in Brainstorm Cell Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on May 6, 2026 at 5:55 pm IST). Based on Brainstorm Cell Therapeutics Inc share’s latest price of $0.69 as on May 6, 2026 at 12:49 am IST, you will get 14.4928 shares of Brainstorm Cell Therapeutics Inc. Learn more about fractional shares .